The vaccine is being withdrawn worldwide just months after the pharmaceutical giant admitted for the first time in court documents that the vaccine can in rare cases cause side effects in the form of blood clots, among other things, skriver The Telegraph.
However, according to the manufacturer, the decision to withdraw the vaccine is purely market-based. In a statement, Astra Zeneca writes that there is now a surplus of updated vaccines, which has led to reduced demand for the company’s vaccine Vaxzevria.
In 2022, a study found that Astra Zeneca’s vaccine increased the risk of an unusual blood clot. The risk was 30 percent higher compared to Pfizer’s covid vaccine, writes TT. Astra Zeneca’s vaccine was paused for most age groups in Sweden by the Public Health Authority as early as March 2021, after suspected cases of blood clots combined with low levels of blood platelets (thrombocytopenia) in a few people. In July of the same year, the authority decided to completely phase out the use of Astra Zeneca’s vaccine.
Read also:
Astra Zeneca is sued for covid vaccine
Astra Zeneca’s vaccine is being phased out
The Public Health Agency stops the use of Astra Zeneca’s vaccine
Lakartidningen.se 2024-05-08
